Emma S. Battle Sells 1,693 Shares of Nu Skin Enterprises, Inc. (NYSE:NUS) Stock

Nu Skin Enterprises, Inc. (NYSE:NUS) Director Emma S. Battle sold 1,693 shares of Nu Skin Enterprises stock in a transaction that occurred on Friday, February 21st. The shares were sold at an average price of $7.73, for a total value of $13,086.89. Following the completion of the sale, the director now owns 17,530 shares in the company, valued at approximately $135,506.90. This trade represents a 8.81 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Nu Skin Enterprises Price Performance

Shares of NYSE:NUS opened at $8.11 on Wednesday. The firm has a market capitalization of $402.98 million, a price-to-earnings ratio of -2.75 and a beta of 1.17. The company has a debt-to-equity ratio of 0.56, a current ratio of 1.82 and a quick ratio of 1.17. The business’s 50 day simple moving average is $6.89 and its 200-day simple moving average is $7.29. Nu Skin Enterprises, Inc. has a 12 month low of $5.95 and a 12 month high of $14.04.

Nu Skin Enterprises (NYSE:NUS) last posted its earnings results on Thursday, February 13th. The company reported $0.38 EPS for the quarter, topping analysts’ consensus estimates of $0.24 by $0.14. The company had revenue of $445.55 million for the quarter, compared to the consensus estimate of $441.10 million. Nu Skin Enterprises had a positive return on equity of 5.86% and a negative net margin of 8.46%. As a group, equities analysts forecast that Nu Skin Enterprises, Inc. will post 1.05 earnings per share for the current fiscal year.

Nu Skin Enterprises Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, March 5th. Shareholders of record on Monday, February 24th will be given a dividend of $0.06 per share. This represents a $0.24 dividend on an annualized basis and a yield of 2.96%. The ex-dividend date is Monday, February 24th. Nu Skin Enterprises’s payout ratio is currently -8.14%.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on NUS shares. DA Davidson reduced their target price on Nu Skin Enterprises from $11.00 to $7.00 and set a “neutral” rating for the company in a report on Friday, December 20th. StockNews.com upgraded shares of Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research note on Tuesday.

Institutional Trading of Nu Skin Enterprises

Several large investors have recently modified their holdings of NUS. Mackenzie Financial Corp raised its position in shares of Nu Skin Enterprises by 406.1% during the 4th quarter. Mackenzie Financial Corp now owns 60,595 shares of the company’s stock worth $418,000 after purchasing an additional 48,621 shares during the last quarter. Public Employees Retirement System of Ohio raised its holdings in shares of Nu Skin Enterprises by 28.5% in the fourth quarter. Public Employees Retirement System of Ohio now owns 7,976 shares of the company’s stock worth $55,000 after acquiring an additional 1,768 shares during the last quarter. PharVision Advisers LLC purchased a new stake in shares of Nu Skin Enterprises in the fourth quarter valued at $561,000. Squarepoint Ops LLC lifted its position in shares of Nu Skin Enterprises by 31.0% in the fourth quarter. Squarepoint Ops LLC now owns 180,151 shares of the company’s stock valued at $1,241,000 after acquiring an additional 42,601 shares in the last quarter. Finally, Two Sigma Advisers LP increased its position in Nu Skin Enterprises by 61.2% during the 4th quarter. Two Sigma Advisers LP now owns 944,000 shares of the company’s stock worth $6,504,000 after purchasing an additional 358,400 shares in the last quarter. 82.84% of the stock is currently owned by institutional investors and hedge funds.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.